title: Effect of Simvastatin, Coenzyme Q10, Resveratrol, Acetylcysteine and Acetylcarnitine on Mitochondrial Respiration.
abstract: Some therapeutic and/or adverse effects of drugs may be related to their effects on mitochondrial function. The effects of simvastatin, resveratrol, coenzyme Q10, acetylcysteine, and acetylcarnitine on Complex I-, Complex II-, or Complex IV-linked respiratory rate were determined in isolated brain mitochondria. The protective effects of these biologically active compounds on the calcium-induced decrease of the respiratory rate were also studied. We observed a significant inhibitory effect of simvastatin on mitochondrial respiration (IC50 = 24.0 μM for Complex I-linked respiration, IC50 = 31.3 μM for Complex II-linked respiration, and IC50 = 42.9 μM for Complex IV-linked respiration); the inhibitory effect of resveratrol was found at very high concentrations (IC50 = 162 μM for Complex I-linked respiration, IC50 = 564 μM for Complex II-linked respiration, and IC50 = 1454 μM for Complex IV-linked respiration). Concentrations required for effective simvastatin- or resveratrol-induced inhibition of mitochondrial respiration were found much higher than concentrations achieved under standard dosing of these drugs. Acetylcysteine and acetylcarnitine did not affect the oxygen consumption rate of mitochondria. Coenzyme Q10 induced an increase of Complex I-linked respiration. The increase of free calcium ions induced partial inhibition of the Complex I+II-linked mitochondrial respiration, and all tested drugs counteracted this inhibition. None of the tested drugs showed mitochondrial toxicity (characterized by respiratory rate inhibition) at drug concentrations achieved at therapeutic drug intake. Resveratrol, simvastatin, and acetylcarnitine had the greatest neuroprotective potential (characterized by protective effects against calcium-induced reduction of the respiratory rate).
authors.affiliation: Department of Psychiatry, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic.
authors.forename: Z
authors.initials: Z
authors.lastname: Fišar
authors.affiliation: Department of Psychiatry, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic.
authors.forename: J
authors.initials: J
authors.lastname: Hroudová
authors.affiliation: Department of Psychiatry, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic.
authors.forename: N
authors.initials: N
authors.lastname: Singh
authors.affiliation: Department of Biology, Faculty of Science, University J. E. Purkyně in Ústí nad Labem, Czech Republic.
authors.forename: A
authors.initials: A
authors.lastname: Kopřivová
authors.affiliation: Department of Biology, Faculty of Science, University J. E. Purkyně in Ústí nad Labem, Czech Republic.
authors.forename: D
authors.initials: D
authors.lastname: Macečková
mesh_terms: D000108:Acetylcarnitine / Q000494:pharmacology; D000111:Acetylcysteine / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000187:drug effects; D019069:Cell Respiration / Q000187:drug effects; D003576:Electron Transport Complex IV / Q000378:metabolism; D008928:Mitochondria / Q000187:drug effects* / Q000378:metabolism; D018696:Neuroprotective Agents / Q000494:pharmacology*; D010101:Oxygen Consumption / Q000187:drug effects; D000077185:Resveratrol; D019821:Simvastatin / Q000494:pharmacology; D013267:Stilbenes / Q000494:pharmacology; D013552:Swine; D014451:Ubiquinone / Q000031:analogs & derivatives / Q000494:pharmacology
chemical_list: D018696:Neuroprotective Agents; D013267:Stilbenes; D014451:Ubiquinone; D000108:Acetylcarnitine; D019821:Simvastatin; D003576:Electron Transport Complex IV; C024989:coenzyme Q10; D000077185:Resveratrol; D000111:Acetylcysteine